Literature DB >> 21116236

Breast cancer: challenges, controversies, breakthroughs.

Lisa Hutchinson.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 21116236     DOI： 10.1038/nrclinonc.2010.192

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702
  1 in total
  57 in total

1.  Differentiation of cancer cells in two-dimensional and three-dimensional breast cancer models by Raman spectroscopy.

Authors:  Nur P Damayanti; Yi Fang; Mukti R Parikh; Ana Paula Craig; Julia Kirshner; Joseph Irudayaraj
Journal:  J Biomed Opt       Date:  2013-11       Impact factor: 3.170

2.  Polymeric nanoassemblies for enrichment and detection of peptides and proteins in human breast milk.

Authors:  Bo Zhao; Jingjing Gao; Mahalia A C Serrano; Kathleen F Arcaro; S Thayumanavan; Richard W Vachet
Journal:  Anal Bioanal Chem       Date:  2020-01-10       Impact factor: 4.142

3.  Inhibition of breast cancer cell proliferation through disturbance of the calcineurin/NFAT pathway by human herpesvirus 6B U54 tegument protein.

Authors:  Mathieu Iampietro; Annie Gravel; Louis Flamand
Journal:  J Virol       Date:  2014-08-13       Impact factor: 5.103

4.  Multifunctional Cu39S28 Hollow Nanopeanuts for In Vivo Targeted Photothermal Chemotherapy.

Authors:  Lihua Li; Xianfeng Yang; Xiaoming Hu; Yao Lu; Liping Wang; Mingying Peng; Hong Xia; Qingshui Yin; Yu Zhang; Gang Han
Journal:  J Mater Chem B       Date:  2017-06-08       Impact factor: 6.331

5.  Curcumin inhibits growth of human breast cancer cells through demethylation of DLC1 promoter.

Authors:  Yufei Liu; Jun Zhou; Yuchang Hu; Junjie Wang; Chengfu Yuan
Journal:  Mol Cell Biochem       Date:  2016-11-10       Impact factor: 3.396

6.  RAS pathway biomarkers for breast cancer prognosis.

Authors:  Lauren L Siewertsz van Reesema; Michael P Lee; Vasilena Zheleva; Janet S Winston; Caroline F O'Connor; Roger R Perry; Richard A Hoefer; Amy H Tang
Journal:  Clin Lab Int       Date:  2016-11

Review 7.  Taspase1: a 'misunderstood' protease with translational cancer relevance.

Authors:  D Wünsch; A Hahlbrock; S Jung; T Schirmeister; J van den Boom; O Schilling; S K Knauer; R H Stauber
Journal:  Oncogene       Date:  2015-12-14       Impact factor: 9.867

8.  KMT2C is a potential biomarker of prognosis and chemotherapy sensitivity in breast cancer.

Authors:  Xinhua Liu; Rongfang Qiu; Min Xu; Miaomiao Meng; Siyu Zhao; Jiansong Ji; Yang Yang
Journal:  Breast Cancer Res Treat       Date:  2021-07-08       Impact factor: 4.872

9.  Bioinformatics analysis to screen key prognostic genes in the breast cancer tumor microenvironment.

Authors:  Qian Ye; Xiaowen Han; Zhengsheng Wu
Journal:  Bioengineered       Date:  2020-12       Impact factor: 3.269

10.  Enhanced tumor delivery and antitumor activity in vivo of liposomal doxorubicin modified with MCF-7-specific phage fusion protein.

Authors:  Tao Wang; William C Hartner; James W Gillespie; Kulkarni P Praveen; Shenghong Yang; Leslie A Mei; Valery A Petrenko; Vladimir P Torchilin
Journal:  Nanomedicine       Date:  2013-09-09       Impact factor: 5.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.